Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

NCT00803010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft Versus Host Disease

Interventions

DRUG: Tacrolimus (TAC)
DRUG: Methotrexate (MTX)
DRUG: Rapamycin (RAPA)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute